SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-057105
Filing Date
2023-07-14
Accepted
2023-07-14 16:30:11
Documents
14
Period of Report
2023-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181696-8k_aditxt.htm   iXBRL 8-K 33420
2 CERTIFICATE OF DESIGNATION OF SERIES C PREFERRED STOCK, DATED JULY 11, 2023 ea181696ex3-1_aditxt.htm EX-3.1 18379
3 SUBSCRIPTION AND INVESTMENT REPRESENTATION AGREEMENT, DATED JULY 11, 2023, BY AN ea181696ex10-1_aditxt.htm EX-10.1 39204
  Complete submission text file 0001213900-23-057105.txt   284935

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adtx-20230711.xsd EX-101.SCH 2953
5 XBRL LABEL FILE adtx-20230711_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE adtx-20230711_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT ea181696-8k_aditxt_htm.xml XML 3806
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 231089433
SIC: 2834 Pharmaceutical Preparations